These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 16647033)

  • 1. A biosensor-based approach toward purification and crystallization of G protein-coupled receptors.
    Navratilova I; Pancera M; Wyatt RT; Myszka DG
    Anal Biochem; 2006 Jun; 353(2):278-83. PubMed ID: 16647033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubilization, stabilization, and purification of chemokine receptors using biosensor technology.
    Navratilova I; Sodroski J; Myszka DG
    Anal Biochem; 2005 Apr; 339(2):271-81. PubMed ID: 15797568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyzing ligand and small molecule binding activity of solubilized GPCRs using biosensor technology.
    Navratilova I; Dioszegi M; Myszka DG
    Anal Biochem; 2006 Aug; 355(1):132-9. PubMed ID: 16762304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrostatic modeling of peptides derived from the V3-loop of HIV-1 gp120: implications of the interaction with chemokine receptor CCR5.
    Morikis D; Rizos AK; Spandidos DA; Krambovitis E
    Int J Mol Med; 2007 Mar; 19(3):343-51. PubMed ID: 17273779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance profile of a neutralizing anti-HIV monoclonal antibody, KD-247, that shows favourable synergism with anti-CCR5 inhibitors.
    Yoshimura K; Shibata J; Kimura T; Honda A; Maeda Y; Koito A; Murakami T; Mitsuya H; Matsushita S
    AIDS; 2006 Oct; 20(16):2065-73. PubMed ID: 17053352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-scale expression and purification of the major HIV-1 coreceptor CCR5 and characterization of its interaction with RANTES.
    Nisius L; Rogowski M; Vangelista L; Grzesiek S
    Protein Expr Purif; 2008 Oct; 61(2):155-62. PubMed ID: 18588983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection and characterization of an HIV-1 gp120-binding affibody ligand.
    Wikman M; Rowcliffe E; Friedman M; Henning P; Lindholm L; Olofsson S; Ståhl S
    Biotechnol Appl Biochem; 2006 Sep; 45(Pt 2):93-105. PubMed ID: 16712522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic alcohol drinking on receptor-binding, internalization, and degradation of human immunodeficiency virus 1 envelope protein gp120 in hepatocytes.
    Singh AK; Jiang Y; Gupta S
    Alcohol; 2007 Dec; 41(8):591-606. PubMed ID: 17980997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for the interaction between focal adhesion kinase and CD4.
    Garron ML; Arthos J; Guichou JF; McNally J; Cicala C; Arold ST
    J Mol Biol; 2008 Feb; 375(5):1320-8. PubMed ID: 18078954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capture and reconstitution of G protein-coupled receptors on a biosensor surface.
    Stenlund P; Babcock GJ; Sodroski J; Myszka DG
    Anal Biochem; 2003 May; 316(2):243-50. PubMed ID: 12711346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of surface-based assays for transmembrane proteins: selective immobilization of functional CCR5, a G protein-coupled receptor.
    Silin VI; Karlik EA; Ridge KD; Vanderah DJ
    Anal Biochem; 2006 Feb; 349(2):247-53. PubMed ID: 16298323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
    Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
    J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry.
    Blish CA; Nedellec R; Mandaliya K; Mosier DE; Overbaugh J
    AIDS; 2007 Mar; 21(6):693-702. PubMed ID: 17413690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular motions in HIV-1 gp120 mutants reveal their preferences for different conformations.
    Liu SQ; Liu CQ; Fu YX
    J Mol Graph Model; 2007 Jul; 26(1):306-18. PubMed ID: 17227719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detergent screening of a G-protein-coupled receptor using serial and array biosensor technologies.
    Rich RL; Miles AR; Gale BK; Myszka DG
    Anal Biochem; 2009 Mar; 386(1):98-104. PubMed ID: 19135021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ligand-based and receptor-based virtual screening of HIV entry inhibitors for the CXCR4 and CCR5 receptors using 3D ligand shape matching and ligand-receptor docking.
    Pérez-Nueno VI; Ritchie DW; Rabal O; Pascual R; Borrell JI; Teixidó J
    J Chem Inf Model; 2008 Mar; 48(3):509-33. PubMed ID: 18298095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV pseudovirion vaccine exposing Env "fusion intermediates"-response to immunisation in human CD4/CCR5-transgenic rats.
    Bosch V; Pfeiffer T; Devitt G; Allespach I; Ebensen T; Emerson V; Guzman CA; Keppler OT
    Vaccine; 2009 Apr; 27(16):2202-12. PubMed ID: 19428834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypic coreceptor analysis.
    Sierra S; Kaiser R; Thielen A; Lengauer T
    Eur J Med Res; 2007 Oct; 12(9):453-62. PubMed ID: 17933727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of glucagon receptors in tetracycline-inducible HEK293S GnT1- stable cell lines: an approach toward purification of receptor protein for structural studies.
    Unson CG
    Biopolymers; 2008; 90(3):287-96. PubMed ID: 18260137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and development of small-molecule chemokine coreceptor CCR5 antagonists.
    Palani A; Tagat JR
    J Med Chem; 2006 May; 49(10):2851-7. PubMed ID: 16686527
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.